Hepatitis C virus attributable liver cancer in the country of Georgia, 2015–2019: a case–control study
Open Access
- 27 September 2024
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-11
Abstract
Background: Hepatitis C virus (HCV) infection can lead to a type of primary liver cancer called hepatocellular carcinoma (HCC). Georgia, a high HCV prevalence country, started an HCV elimination program in 2015. In addition to tracking incidence and mortality, surveillance for the HCV-attributable fraction of HCC is an important indicator of the program’s impact. This study assesses HCV infection-attributable HCC in the Georgian population. Methods: This case–control study utilized HCV programmatic and Georgian Cancer Registry data from 2015–2019. Bivariate logistic regression and age- and sex-stratified analyses assessed HCV and liver cancer association. HCV-attributable liver cancer proportions for the HCV-exposed and total population were calculated. A sub-analysis was performed for HCC cases specifically. Results: The total study population was 3874 with 496 liver cancer cases and 3378 controls. The odds for HCV-infected individuals developing liver cancer was 20.1 (95% confidence interval [CI] 15.97–25.37), and the odds of developing HCC was 16.84 (95% CI 12.01–23.83) compared to the HCV-negative group. Odds ratios varied across strata, with HCV-infected older individuals and women having higher odds of developing both liver cancer and HCC. A large proportion of liver cancer and HCC can be attributed to HCV in HCV-infected individuals; however, in the general population, the burden of liver cancer and HCC cannot be explained by HCV alone. Conclusion: HCV was significantly associated with a higher risk of developing liver cancer and HCC in the Georgian population. In addition, given Georgia’s high HCV burden, increased HCC monitoring in HCV-infected patients is needed.Keywords
Funding Information
- Lund University
This publication has 26 references indexed in Scilit:
- Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwideInternational Journal of Cancer, 2018
- HCV elimination — lessons learned from a small Eurasian country, GeorgiaNature Reviews Gastroenterology & Hepatology, 2017
- Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry‐based case‐control studyCancer, 2017
- Gender-Related Differences in Hepatocellular Carcinoma: Does Sex Matter?Journal of Vascular and Interventional Radiology, 2016
- Population attributable fractions of risk factors for hepatocellular carcinoma in the United StatesCancer, 2016
- Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinomaBMC Gastroenterology, 2012
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Gender Differences in Cancer Screening Beliefs, Behaviors, and Willingness to ParticipateAmerican Journal of Men's Health, 2011
- Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection†Hepatology, 2010
- Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 ProductionScience, 2007